Incredible story about how American Heart Association President Dr John Warner suffered a cardiac arrest after his presidential address and was subsequently saved by two bystanders. This story emphasizes the fortune of being in the right place at the right time, but more importantly, the public value of knowing CPR.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart Failure
December 22, 2017
Bansal and colleagues describe survival after left ventricular assist device placement for patients with end-stage renal disease (ESRD), based on Medicare claims associated with data in the United States Renal Data System registry. Prognosis for these patients was very poor compared to patients without ESRD, particularly in the short-term.
November 16, 2017
The incoming issue of the Journal comes with an interesting group of papers revolving around a provocative topic: work from Seattle on the absence of predictive value of standard pulmonary function tests in LVAD surgery. Vivek Rao takes the opportunity to present his thoughts in this brief editorial, the important central message of which cannot be
November 13, 2017
The Hospital Readmissions Reduction Program (HRRP) was established as part of the Affordable Care Act in the US with the goal of adding an incentive for quality care that reduced hospital readmission rates. HRRP reduces Medicare reimbursement for hospitals with excess readmissions.
November 3, 2017
Patient Care
Ambulances specially tailored to respond to cardiac emergencies will go into service in Goa, India, at the beginning of 2018.
November 3, 2017
Kamperidis and colleagues report that left ventricular (LV) functional recovery after mitral valve (MV) repair for severe secondary mitral regurgitation is associated with improved patient outcomes.
October 27, 2017
A measured succinct reflection on MagLev and older ventricular assist devices, on the occasion of a relevant 'expert opinion' paper on the topic.
October 12, 2017
The Impella RP device was approved by the FDA for use as a temporary percutaneous assist for the right ventricle, as announced by Abiomed. Use is approved for up to 14 days for a variety of indications including post MI, heart transplant, open heart surgery, or right heart failure after LVAD implant.
September 29, 2017
Patient Care
A Brazilian woman ran a road race in Rio de Janiero, powered by the transplanted heart of a German Olympian that she had received only a year earlier.
September 19, 2017
The authors queried the UNOS heart transplantation database to determine if LVAD device-related complications (DRCs) were associated with worse postoperative graft survival. The 5 categories of DRCs were as follows: device thrombosis, infection, device malfunction, life-threatening arrhythmias, and others.